Prof Mark Ferguson - Keynote speaker at 2nd Scar Meeting

Prof Mark Ferguson, CEO will be speaking on:

1. “Zesteem (17β Estradiol) for the acceleration of re-epithelialisation, particularly of skin graft donor sites”.

2. “Prevention and reduction of scarring in the skin: from laboratory research to clinical therapeutic”

3. “Juvista (TGF3) a potential new human pharmacological agent for the prevention and reduction of scarring”